High‐powered percutaneous microwave ablation of stage I medically inoperable non‐small cell lung cancer: A preliminary study
- 8 May 2013
- journal article
- clinical trial
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 57 (4) , 466-474
Abstract
Purpose: To retrospectively evaluate the feasibility and outcome of using high‐powered percutaneous microwave ablation (MWA) in treating medically inoperable early stage non‐small cell lung cancer.Materials and Methods: From November 2010 to June 2012, 15 patients underwent CT‐guided MWA of 15 tumours in 16 sessions. One patient had a second ablation session for local tumour progression. Each tumour had a diameter of 40 mm or less (median 24 mm). Treatment outcome was evaluated using modified response evaluation criteria in solid tumours criteria based on follow‐up contrast‐enhanced CT studies and 18‐F fluorodeoxyglucose positron emission tomography scans.Results: Thirty‐three ablation cycles of 15 tumours were performed in 16 sessions (2.1 per session), with a median duration of 2.5 min per ablation. Treatment was completed in all cases with no 30‐day mortality. At a median follow‐up period of 1 year, local progression was identified following 5/16 (31%) ablation sessions. Eleven out of 16 (69%) of MWAs had shown local treatment response, with 9/11 displaying complete response and 2/11 displaying partial response. Local progression on follow up was predominantly seen in pleural‐based tumours that were greater than 30 mm in longest axial diameter (4/5 cases). The main adverse event was a pneumothorax, which occurred in 10/16 (63%) of procedures, but a chest tube was only required in 2/16 (13%) cases.Conclusion: Percutaneous MWA in early stage non‐small cell lung cancer is well tolerated and has promising midterm outcomes.Keywords
This publication has 24 references indexed in Scilit:
- Image-guided Thermal Ablation of Lung MalignanciesRadiology, 2011
- Evaluation of Treatment Response After Nonoperative Therapy for Early-Stage Non-Small Cell Lung CarcinomaThe Cancer Journal, 2011
- 18F-FDG PET/CT for the Prediction and Detection of Local Recurrence After Radiofrequency Ablation of Malignant Lung LesionsJournal of Nuclear Medicine, 2010
- Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and DevicesJournal of Vascular and Interventional Radiology, 2010
- Alternatives to Surgery for Early Stage Non-Small Cell Lung Cancer-Ready for Prime Time?Current Treatment Options in Oncology, 2010
- Thermal Ablation of Lung Tissue: In Vivo Experimental Comparison of Microwave and RadiofrequencyCardioVascular and Interventional Radiology, 2010
- Radiofrequency Ablation of Lung TumorsClinics in Chest Medicine, 2010
- Microwave Ablation Compared with Radiofrequency Ablation in Lung Tissue–Is Microwave Not Just for Popcorn Anymore?Radiology, 2009
- Radiofrequency ablation for treatment of medically inoperable stage I non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Percutaneous Radiofrequency Ablation of Malignancies in the LungAmerican Journal of Roentgenology, 2000